Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Page

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Drugs|October 7, 2020
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic AgentMario Cazzola, Clive Page, Paola Rogliani, et al.
British Journal of Clinical Pharmacology|May 6, 2022
Dual bronchodilation for the treatment of COPD: From bench to bedsideMario Cazzola, Clive Page, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2026
Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implicationsMaria Gabriella Matera, Clive Page, Luigino Calzetta, et al.
Drugs|August 11, 2016
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary DiseaseMaria Gabriella Matera, Clive Page, Paola Rogliani, et al.
Pulmonary Pharmacology & Therapeutics|April 30, 2018
Impact of doxofylline in COPD: A pairwise meta-analysisMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Pharmacological Reviews|July 15, 2024
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical ApplicationLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Journal of Pharmaceutical Sciences|July 30, 2015
Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for InhalationJoanna Muddle, Darragh Murnane, Irene Parisini, et al.
Pulmonary Pharmacology & Therapeutics|June 3, 2021
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combinationCarmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Drugs|October 7, 2020
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic AgentMario Cazzola, Clive Page, Paola Rogliani, et al.
British Journal of Clinical Pharmacology|May 6, 2022
Dual bronchodilation for the treatment of COPD: From bench to bedsideMario Cazzola, Clive Page, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 13, 2026
Pharmacological interactions between asthma and T2DM therapies: clinical and metabolic implicationsMaria Gabriella Matera, Clive Page, Luigino Calzetta, et al.
Drugs|August 11, 2016
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary DiseaseMaria Gabriella Matera, Clive Page, Paola Rogliani, et al.
Pulmonary Pharmacology & Therapeutics|April 30, 2018
Impact of doxofylline in COPD: A pairwise meta-analysisMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Pharmacological Reviews|July 15, 2024
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical ApplicationLuigino Calzetta, Clive Page, Maria Gabriella Matera, et al.
Journal of Pharmaceutical Sciences|July 30, 2015
Interaction of Formulation and Device Factors Determine the In Vitro Performance of Salbutamol Sulphate Dry Powders for InhalationJoanna Muddle, Darragh Murnane, Irene Parisini, et al.
Pulmonary Pharmacology & Therapeutics|June 3, 2021
The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combinationCarmen Lorena Robaina Cabrera, Sandra Keir-Rudman, Nick Horniman, et al.
Pageof 11